LIPELLA PHARMACEUTICALS INC. Quarterly Debt-to-equity in % from Q3 2023 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Lipella Pharmaceuticals Inc. quarterly Debt-to-equity history and growth rate from Q3 2023 to Q2 2024.
  • Lipella Pharmaceuticals Inc. Debt-to-equity for the quarter ending June 30, 2024 was 21.9 %.
Debt-to-equity, Quarterly (%)
Period Value YoY Chg Change % Date
Q2 2024 21.9 Jun 30, 2024
Q1 2024 18 Mar 31, 2024
Q4 2023 18 Dec 31, 2023
Q3 2023 22.1 Sep 30, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.